2025年1月13日 · Research & Development at Janssen: innovations which lead to better insights into diseases As far as Janssen is concerned, working on incremental improvements to healthcare is not enough. We leverage our scientific expertise to transform entire disease categories and make significant contributions to global public health. In our six priority …

J&J is advancing the next era of medical innovation through our continuous R&D investments, totaling $77.7 billion since 2016. 1 However, patients’ cost exposure and access challenges are increasing because of distorted insurance benefit design and regulatory hurdles.

2025年2月28日 · We have carefully selected our applications to support high-priority projects across our R&D pipeline, from Discovery to Clinical Development: Discovery Generating artificial intelligence (AI)-driven, high-value biological insights and targets using rich, multi-modal data

“The past is of little interest to me. I am more interested in the present and particularly the future.” Dr Paul Janssen

2025年1月13日 · Janssen in Belgium is not only active in developing medicines — we produce and distribute them as well. Our distribution department plays a key role in Johnson & Johnson's global supply chain, which covers all of the steps required to produce and distribute medicines, medical devices and consumer products. Thanks to the European distribution center in La …

PRODUCT: PREZISTA® 600MG Tblt, 60 Count. NDC: 5967656201; Operating Company: Janssen Products, LP Type: Trade; Case Size: 12; Min Order Qty: 12; Case Weight (lbs). 3 ...

2024年9月26日 · Actelion Specialty Pharmacies. Below are JOM's current Authorized Distributors of Record. Please select the authorized distributors below to see the products that they are authorized to distribute.

cardinal health p.r. 120, inc. cardinal health specialty pharmaceutical distribution : cardinal health, inc. cesar castillo, inc. curascript sd specialty distribution division of express scripts (previously priority healthcare) dakota drug, inc. dms pharmaceutical group, inc. drogueria betances, inc. harvard drug group, llc (division of ...

O exemplo do nosso fundador, Dr. Paul Janssen, continua a estar no centro de tudo o que fazemos para combater a doença e melhorar a vida dos doentes.

2024年9月24日 · Johnson & Johnson（法人名：ヤンセンファーマ株式会社、本社：東京都千代田区、代表取締役社長：關口修平、以下「J&J」）は24日、エンドセリン受容体拮抗薬マシテンタン10mgとホスホジエステラーゼ5阻害薬タダラフィル40mgとの配合剤である「ユバンシ ® 配 …